LBPH has 36-month beta value of 1.09. Analysts have mixed views on the stock, with 5 analysts rating it as a “buy,” 3 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for LBPH is 33.70M, and currently, short sellers hold a 15.34% ratio of that float. The average trading volume of LBPH on November 06, 2024 was 1.61M shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
LBPH) stock’s latest price update
Longboard Pharmaceuticals Inc (NASDAQ: LBPH)’s stock price has soared by 0.20 in relation to previous closing price of 59.65. Nevertheless, the company has seen a gain of 0.12% in its stock price over the last five trading days. businesswire.com reported 2024-10-31 that NEW ORLEANS–(BUSINESS WIRE)–Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Longboard Pharmaceuticals, Inc. (NasdaqGM: LBPH) to H. Lundbeck A/S. Under the terms of the proposed transaction, shareholders of Longboard will receive $60.00 in cash for each share of Longboard that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate,.
LBPH’s Market Performance
Longboard Pharmaceuticals Inc (LBPH) has experienced a 0.12% rise in stock performance for the past week, with a 77.73% rise in the past month, and a 61.58% rise in the past quarter. The volatility ratio for the week is 0.58%, and the volatility levels for the past 30 days are at 2.02% for LBPH. The simple moving average for the last 20 days is 4.51% for LBPH’s stock, with a simple moving average of 105.90% for the last 200 days.
Analysts’ Opinion of LBPH
Many brokerage firms have already submitted their reports for LBPH stocks, with Truist repeating the rating for LBPH by listing it as a “Buy.” The predicted price for LBPH in the upcoming period, according to Truist is $60 based on the research report published on September 10, 2024 of the current year 2024.
Cantor Fitzgerald, on the other hand, stated in their research note that they expect to see LBPH reach a price target of $90, previously predicting the price at $60. The rating they have provided for LBPH stocks is “Overweight” according to the report published on July 01st, 2024.
Robert W. Baird gave a rating of “Outperform” to LBPH, setting the target price at $36 in the report published on May 01st of the current year.
LBPH Trading at 38.73% from the 50-Day Moving Average
After a stumble in the market that brought LBPH to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -0.30% of loss for the given period.
Volatility was left at 2.02%, however, over the last 30 days, the volatility rate increased by 0.58%, as shares surge +79.14% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +69.77% upper at present.
During the last 5 trading sessions, LBPH rose by +0.10%, which changed the moving average for the period of 200-days by +129.32% in comparison to the 20-day moving average, which settled at $57.19. In addition, Longboard Pharmaceuticals Inc saw 891.21% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at LBPH starting from Kaye Randall, who sale 16,667 shares at the price of $59.03 back on Oct 15 ’24. After this action, Kaye Randall now owns 17,920 shares of Longboard Pharmaceuticals Inc, valued at $983,936 using the latest closing price.
Kaye Randall, the CMO of Longboard Pharmaceuticals Inc, sale 16,666 shares at $31.64 during a trade that took place back on Sep 16 ’24, which means that Kaye Randall is holding 17,920 shares at $527,318 based on the most recent closing price.
Stock Fundamentals for LBPH
Current profitability levels for the company are sitting at:
- -9113.5 for the present operating margin
- 0.38 for the gross margin
The net margin for Longboard Pharmaceuticals Inc stands at -8092.25. The total capital return value is set at -0.24. Equity return is now at value -36.71, with -34.15 for asset returns.
Based on Longboard Pharmaceuticals Inc (LBPH), the company’s capital structure generated 0.01 points at debt to capital in total, while cash flow to debt ratio is standing at -15.18. The debt to equity ratio resting at 0.01. The interest coverage ratio of the stock is -144.09.
Currently, EBITDA for the company is -56.75 million with net debt to EBITDA at 0.15. When we switch over and look at the enterprise to sales, we see a ratio of 290107.2. The liquidity ratio also appears to be rather interesting for investors as it stands at 20.95.
Conclusion
To put it simply, Longboard Pharmaceuticals Inc (LBPH) has had a better performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
